Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q3 2024 · 141 positions · Total reported value $1.77B · Top-10 concentration 24.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, Invenomic Capital Management LP disclosed 141 equity positions with a combined reported value of $1.77B. The filing implies a diversified portfolio: its ten largest positions account for 24.3% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q3 2024 were GPN ($69.88M), MTB ($50.19M), VTRS ($43.65M). By sector, the heaviest allocations are Consumer Discretionary 21.7%, Technology 21.5%. Versus the prior quarter, allocation shifted toward Consumer Staples (+6.3pp), Technology (+5.0pp) and away from Energy (-0.7pp), Consumer Discretionary (-1.3pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 60% of names.

The largest new positions opened in Q3 2024 were PGNY ($29.51M), XRAY ($23.72M), HELE ($14.30M).

Of the 35 positions fully exited versus the prior quarter, the largest were SPY ($136.06M), APTV ($26.64M), FTDR ($22.39M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • PGNY PROGYNY INC · $29.51M
  • XRAY DENTSPLY SIRONA INC · $23.72M
  • HELE HELEN OF TROY LTD · $14.30M
  • JACK JACK IN THE BOX INC · $11.80M
  • SSYS STRATASYS LTD · $10.92M
  • CRM SALESFORCE INC · $10.74M
  • COP CONOCOPHILLIPS · $9.77M
  • CAG CONAGRA BRANDS INC · $8.49M

Fully Exited (vs previous quarter)

  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $136.06M
  • APTV APTIV PLC · prev qtr: $26.64M
  • FTDR FRONTDOOR INC · prev qtr: $22.39M
  • OPLN OPENLANE INC · prev qtr: $18.61M
  • FL FOOT LOCKER INC · prev qtr: $16.91M
  • EBAY EBAY INC. · prev qtr: $14.59M
  • PINC PGIM ETF TR · prev qtr: $14.19M
  • SUI SUN CMNTYS INC · prev qtr: $12.07M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 21.5%
Health Care 11.8%
Energy 5.9%
Other 21.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 682.26K $69.88M 3.94%
3.94%
Add
2 281.77K $50.19M 2.83%
2.83%
Add
3 3.76M $43.65M 2.46%
2.46%
Reduce
4 611.72K $42.66M 2.40%
2.40%
Reduce
5 626.65K $42.64M 2.40%
2.40%
Reduce
6 5.92M $42.02M 2.37%
2.37%
Reduce
7 584.88K $40.78M 2.30%
2.30%
Reduce
8 263.34K $34.29M 1.93%
1.93%
Reduce
9 1.53M $33.64M 1.90%
1.90%
Reduce
10 429.49K $31.87M 1.80%
1.80%
Reduce
11 857.67K $30.76M 1.73%
1.73%
Add
12 519.38K $29.87M 1.68%
1.68%
Add
13 1.76M $29.51M 1.66%
1.66%
New
14 767.09K $29.39M 1.66%
1.66%
Reduce
15 1.53M $29.21M 1.65%
1.65%
Add
16 188.25K $27.86M 1.57%
1.57%
Reduce
17 606.31K $27.23M 1.53%
1.53%
Reduce
18 2.19M $25.22M 1.42%
1.42%
Add
19 471.70K $25.21M 1.42%
1.42%
Reduce
20 276.59K $24.47M 1.38%
1.38%
Add
21 2.33M $24.40M 1.38%
1.38%
Add
22 472.24K $24.20M 1.36%
1.36%
Add
23 309.05K $24.12M 1.36%
1.36%
Reduce
24 876.73K $23.72M 1.34%
1.34%
New
25 2.87M $23.64M 1.33%
1.33%
Add
26 655.23K $23.01M 1.30%
1.30%
Add
27 184.16K $22.11M 1.25%
1.25%
Reduce
28 1.03M $21.82M 1.23%
1.23%
Add
29 1.15M $21.64M 1.22%
1.22%
Reduce
30 2.69M $21.36M 1.20%
1.20%
Add
31 2.34M $20.21M 1.14%
1.14%
Reduce
32 1.15M $20.00M 1.13%
1.13%
Reduce
33 394.09K $19.97M 1.12%
1.12%
Add
34 2.42M $18.03M 1.02%
1.02%
Reduce
35 175.98K $17.77M 1.00%
1.00%
Add
36 199.12K $17.59M 0.99%
0.99%
Add
37 469.44K $16.60M 0.94%
0.94%
Reduce
38 485.11K $16.37M 0.92%
0.92%
Add
39 287.25K $15.16M 0.85%
0.85%
Add
40 1.87M $14.53M 0.82%
0.82%
Reduce
41 382.06K $14.46M 0.81%
0.81%
Reduce
42 231.26K $14.30M 0.81%
0.81%
New
43 1.50M $14.00M 0.79%
0.79%
Reduce
44 355.52K $13.82M 0.78%
0.78%
Reduce
45 1.47M $13.53M 0.76%
0.76%
Add
46 1.03M $12.98M 0.73%
0.73%
Add
47 445.98K $12.87M 0.72%
0.72%
Reduce
48 154.89K $12.74M 0.72%
0.72%
Reduce
49 921.47K $12.55M 0.71%
0.71%
Add
50 795.69K $12.48M 0.70%
0.70%
Add

FAQ

What did Invenomic Capital Management LP buy in 2024-Q3?

In its 2024-Q3 13F filing, Invenomic Capital Management LP reported 141 equity positions worth $1.77B in aggregate; its largest disclosed positions were GPN ($69.88M), MTB ($50.19M), VTRS ($43.65M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $1.77B of long equity holdings across 141 positions as of 2024-Q3. Top-10 holdings account for 24.3% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →